Synthesis of novel polybrominated benzimidazole derivatives—potential CK2 inhibitors with anticancer and proapoptotic activity E Łukowska-Chojnacka, P Wińska, M Wielechowska, M Poprzeczko, ... Bioorganic & Medicinal Chemistry 24 (4), 735-741, 2016 | 51 | 2016 |
Ciliary proteins Fap43 and Fap44 interact with each other and are essential for proper cilia and flagella beating P Urbanska, E Joachimiak, R Bazan, G Fu, M Poprzeczko, H Fabczak, ... Cellular and Molecular Life Sciences 75, 4479-4493, 2018 | 46 | 2018 |
Mechanisms of immune evasion in acute lymphoblastic leukemia A Pastorczak, K Domka, K Fidyt, M Poprzeczko, M Firczuk Cancers 13 (07), 1536, 2021 | 45 | 2021 |
Ciliary proteins: filling the gaps. Recent advances in deciphering the protein composition of motile ciliary complexes A Osinka, M Poprzeczko, MM Zielinska, H Fabczak, E Joachimiak, ... Cells 8 (7), 730, 2019 | 39 | 2019 |
Ccdc113/Ccdc96 complex, a novel regulator of ciliary beating that connects radial spoke 3 to dynein g and the nexin link R Bazan, A Schröfel, E Joachimiak, M Poprzeczko, G Pigino, D Wloga PLoS genetics 17 (3), e1009388, 2021 | 35 | 2021 |
Rare human diseases: model organisms in deciphering the molecular basis of primary ciliary dyskinesia M Poprzeczko, M Bicka, H Farahat, R Bazan, A Osinka, H Fabczak, ... Cells 8 (12), 1614, 2019 | 34 | 2019 |
PCD Genes—From Patients to Model Organisms and Back to Humans M Niziolek, M Bicka, A Osinka, Z Samsel, J Sekretarska, M Poprzeczko, ... International journal of molecular sciences 23 (3), 1749, 2022 | 17 | 2022 |
Composition and function of the C1b/C1f region in the ciliary central apparatus E Joachimiak, A Osinka, H Farahat, B Świderska, E Sitkiewicz, ... Scientific reports 11 (1), 11760, 2021 | 17 | 2021 |
Integrated modeling of the Nexin-dynein regulatory complex reveals its regulatory mechanism A Ghanaeian, S Majhi, CL McCafferty, B Nami, CS Black, SK Yang, ... Nature Communications 14 (1), 5741, 2023 | 14 | 2023 |
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax K Fidyt, A Pastorczak, J Cyran, NT Crump, A Goral, J Madzio, ... Oncogene 41 (11), 1600-1609, 2022 | 12 | 2022 |
Optimizing the therapeutic potential of tyrosine kinase inhibitors in chemo-immunotherapy of B-cell acute lymphoblastic leukemia involving rituximab K Domka, M Poprzeczko, Z Urbanska, L Komorowski, A Pastorczak, ... Cancer Research 82 (12_Supplement), 3324-3324, 2022 | 1 | 2022 |
Biogeneza rzęski pierwotnej M Poprzeczko, E Joachimiak, D Włoga, H Fabczak Kosmos 67 (1), 179-193, 2018 | 1 | 2018 |
P339: BOOSTING THE EFFICACY OF CD20-TARGETING IMMUNOTHERAPY IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA M Poprzeczko, K Domka, A Pastorczak, K Fidyt, L Komorowski, ... HemaSphere 6, 239-240, 2022 | | 2022 |